戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mmunological profile of the host response to Campylobacter infection.
2 wheeze, atopic sensitization) or symptomatic Campylobacter infection.
3 f culture-independent diagnostic methods for Campylobacter infection.
4 d from restaurants were additional risks for Campylobacter infection.
5  defined as the likelihood of a diagnosis of Campylobacter infection.
6  of the incidence of GBS among patients with Campylobacter infection.
7 an do persons with ciprofloxacin-susceptible Campylobacter infection.
8 ed with the risk of developing GBS following campylobacter infection.
9 the strongest documented association is with Campylobacter infection.
10  illness costs are spent annually because of Campylobacter infection.
11 628-9575 US cases, 526-3830 are triggered by Campylobacter infection.
12 of the gastrointestinal tract as a result of Campylobacter infection.
13 rvoir responsible for up to 80% of the human Campylobacter infections.
14 nducts surveillance for laboratory-confirmed Campylobacter infections.
15 cient to characterize mixed Helicobacter and Campylobacter infections.
16  both Salmonella-Escherichia and Escherichia-Campylobacter infections.
17 out were the most important risk factors for Campylobacter infections.
18 } or any recreational water exposure [OR for Campylobacter infection, 2.7 {CI, 1.5-4.8}; OR for Esche
19 the 28 samples with Salmonella, Shigella, or Campylobacter infection, 93% had detectable fecal lactof
20 ential for understanding the epidemiology of Campylobacter infections, a major worldwide cause of bac
21                Given significant sequelae of Campylobacter infection among preschool aged children, o
22 ntibiotic treatment may reduce the burden of Campylobacter infection and improve growth in children i
23                      The association between Campylobacter infection and subsequent Guillain-Barre sy
24 un metagenomics on stools from 26 cases with Campylobacter infections and 44 healthy family members (
25 dentify risk factors for sporadic intestinal Campylobacter infections and to determine the relative i
26 ck [n=1]; sepsis [n=1]; bone marrow failure, campylobacter infection, and liver disorder [n=1]; and p
27                                              Campylobacter infections are found worldwide and are the
28        The first line of evidence supporting Campylobacter infection as a trigger of GBS is anecdotal
29            In 2012, a multistate outbreak of Campylobacter infections associated with unpasteurized m
30 scertain burden, and can distinguish between Campylobacter infections at the species level.
31 only 9% of nontyphoidal Salmonella and 4% of Campylobacter infections compared with 59% and 55% among
32 ion was associated with greater incidence of Campylobacter infection.CONCLUSIONThis comprehensive ass
33 The negative predictive value for ruling out Campylobacter infection, defined as a posttest probabili
34 to develop best practice recommendations for Campylobacter infection diagnostic testing.
35 t puppy exposure when treating patients with Campylobacter infection, especially when they do not imp
36 rade 3]; diarrhoea and fever associated with Campylobacter infection [grade 3]; recurrence of abdomin
37                                              Campylobacter infection has also been linked to the post
38  variation in the rates of culture-confirmed Campylobacter infection has been consistently observed a
39 estically acquired fluoroquinolone-resistant Campylobacter infection has been documented recently in
40 hemokines by dendritic cells (DCs) following Campylobacter infection has not yet been analyzed.
41         Persons with ciprofloxacin-resistant Campylobacter infection have a longer duration of diarrh
42 on and human health impact of Salmonella and Campylobacter infections have rarely been evaluated at t
43                                              Campylobacter infection in developing countries has not
44 ine candidate for preventing and controlling Campylobacter infection in humans and animal reservoirs.
45                                      Risk of Campylobacter infection in humans has been associated wi
46 , we describe the epidemiology and impact of Campylobacter infection in the first 2 years of life.
47 ones (e.g., ciprofloxacin) are used to treat Campylobacter infections in adults.
48              We describe the epidemiology of Campylobacter infections in the United States during 200
49                                              Campylobacter infection is a leading cause of ovine abor
50           Together, these data indicate that Campylobacter infection is associated with an altered re
51                                              Campylobacter infection is associated with impaired grow
52                                              Campylobacter infection is common in this cohort and ass
53                                              Campylobacter infection is one of the major causes of ov
54                                              Campylobacter infection is the most commonly notified ba
55 echanisms, we evaluated associations between Campylobacter infection, linear growth, and fecal microb
56 e studies have speculated that Salmonella or Campylobacter infection may increase the risk of inflamm
57        We have developed experimental murine Campylobacter infection models which demonstrate efficie
58 icken meat represents an important source of Campylobacter infections of humans world-wide.
59       The gastrointestinal manifestations of Campylobacter infection range from watery diarrhea to se
60 developing world and industrialized nations, Campylobacter infections remain a high priority for rese
61                            One of every 1058 Campylobacter infections results in GBS, and 1 of 158 Ca
62                                     Further, Campylobacter infection stimulated the phosphorylation o
63 nt knowledge about the laboratory aspects of Campylobacter infection that may be pertinent to studies
64 oxacin, an antibiotic of choice for treating Campylobacter infection, through the pore of MOMP reveal
65                                              Campylobacter infection was also associated with increas
66  case-control study of persons with sporadic Campylobacter infection was conducted within 7 FoodNet s
67               Serological evidence of recent Campylobacter infection was detected in 81% of AMAN and
68 11 case patients with diarrhea and confirmed Campylobacter infection was enrolled, along with 1 age-
69                       Among 290 persons with Campylobacter infection who did not take antidiarrheal m